Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of S-1 in Combination With Oxaliplatin and Irinotecan in Patients With Advanced, Recurrent or Metastatic Gastric Cancer

NCT02527785 is registered in ClinicalTrials.gov with Hallym University Medical Center as lead sponsor.

NCT NCT02527785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02527785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of S-1 in Combination With Oxaliplatin and Irinotecan in Patients With Advanced, Recurrent or Metastatic Gastric Cancer
Lead sponsor
Hallym University Medical Center
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2015
Completion date
April 30, 2017
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stomach neoplasm